These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25961524)

  • 1. On the Origins of Hepatitis C Virus NS5B Polymerase Inhibitory Activity Using Machine Learning Approaches.
    Worachartcheewan A; Prachayasittikul V; Anuwongcharoen N; Shoombuatong W; Prachayasittikul V; Nantasenamat C
    Curr Top Med Chem; 2015; 15(18):1814-26. PubMed ID: 25961524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale structure-activity relationship study of hepatitis C virus NS5B polymerase inhibition using SMILES-based descriptors.
    Worachartcheewan A; Prachayasittikul V; Toropova AP; Toropov AA; Nantasenamat C
    Mol Divers; 2015 Nov; 19(4):955-64. PubMed ID: 26164590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors.
    Golub AG; Gurukumar KR; Basu A; Bdzhola VG; Bilokin Y; Yarmoluk SM; Lee JC; Talele TT; Nichols DB; Kaushik-Basu N
    Eur J Med Chem; 2012 Dec; 58():258-64. PubMed ID: 23127989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors.
    Musmuca I; Caroli A; Mai A; Kaushik-Basu N; Arora P; Ragno R
    J Chem Inf Model; 2010 Apr; 50(4):662-76. PubMed ID: 20225870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine.
    Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
    Mol Divers; 2011 Aug; 15(3):645-53. PubMed ID: 20931278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 4-thiazolidinones as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Çakir G; Küçükgüzel İ; Guhamazumder R; Tatar E; Manvar D; Basu A; Patel BA; Zia J; Talele TT; Kaushik-Basu N
    Arch Pharm (Weinheim); 2015 Jan; 348(1):10-22. PubMed ID: 25449674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of HCV NS5B polymerase inhibitors using support vector machine.
    Wang M; Wang K; Yan A; Yu C
    Int J Mol Sci; 2012; 13(4):4033-4047. PubMed ID: 22605964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
    Zhang HX; Li Y; Wang X; Xiao ZT; Wang YH
    Curr Med Chem; 2011; 18(26):4019-28. PubMed ID: 21824089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors.
    Wang M; Zhong M; Yan A; Li L; Yu C
    SAR QSAR Environ Res; 2014; 25(1):1-15. PubMed ID: 24283437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
    PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
    Therese PJ; Manvar D; Kondepudi S; Battu MB; Sriram D; Basu A; Yogeeswari P; Kaushik-Basu N
    J Chem Inf Model; 2014 Feb; 54(2):539-52. PubMed ID: 24460140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors.
    Malik AA; Phanus-Umporn C; Schaduangrat N; Shoombuatong W; Isarankura-Na-Ayudhya C; Nantasenamat C
    J Comput Chem; 2020 Jul; 41(20):1820-1834. PubMed ID: 32449536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M; ElGamacy M; Fares M
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives.
    Beaulieu PL; Bös M; Bousquet Y; Fazal G; Gauthier J; Gillard J; Goulet S; LaPlante S; Poupart MA; Lefebvre S; McKercher G; Pellerin C; Austel V; Kukolj G
    Bioorg Med Chem Lett; 2004 Jan; 14(1):119-24. PubMed ID: 14684311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.
    Zhao C; Wang Y; Ma S
    Eur J Med Chem; 2015 Sep; 102():188-214. PubMed ID: 26276434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and initial optimization of alkoxyanthranilic acid derivatives as inhibitors of HCV NS5B polymerase.
    Parcella K; Nickel A; Beno BR; Sheriff S; Wan C; Wang YK; Roberts SB; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2017 Jan; 27(2):295-298. PubMed ID: 27908764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics.
    Nutho B; Meeprasert A; Chulapa M; Kungwan N; Rungrotmongkol T
    J Biomol Struct Dyn; 2017 Jun; 35(8):1743-1757. PubMed ID: 27236925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies.
    Cao H; Cao R; Zhang H; Zheng X; Gao D
    Curr Med Chem; 2008; 15(15):1462-77. PubMed ID: 18537623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
    Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.
    De Francesco R; Carfí A
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1242-62. PubMed ID: 17869377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.